STAT+: Pharmalittle: Wegovy heart study has docs seeing new possibilities; drugmakers file more ‘continuation’ patents that sideline generic rivals
A new study of Wegovy is expected to have a big impact on how clinicians approach treatment of obesity and heart disease.
by Ed Silverman
Aug 09, 2023
1 minute
Good morning, everyone, and how are you today? We are doing just fine, thank you. Given that this is already the middle of the week and we have survived this far, no reason
You’re reading a preview, subscribe to read more.
Start your free 30 days